New combo therapy shows promise for lymphedema patients

NCT ID NCT06167993

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding a special type of physiotherapy after lymphovenous anastomosis surgery helps people with lymphedema more than physiotherapy alone. Lymphedema is a condition where fluid builds up and causes swelling, often after cancer treatment. The study involved 26 adults with lymphedema from cancer, comparing those who had surgery plus physiotherapy to those who only had physiotherapy. The goal was to see if the combination reduced swelling, improved quality of life, and increased satisfaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Aug 2023

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Between the ages of 18-65, * Having unilateral lower extremity or upper extremity lymphedema, * Being diagnosed with Stage 2 and 3 lymphedema, * Receiving lymphedema therapy for the first time, * Adjuvant chemotherapy for gynecological cancer, * Having completed radiation and surgical treatment at least 3 months and at most 5 years ago, * Patients with lymph vessels seen on lymphangiography, * Patients who have undergone LVA surgery and 1 month has passed since the surgery date * No evidence of disease recurrence at last follow-up visit and * Individuals willing to participate in the study Exclusion Criteria: * Those who do not volunteer to participate in the study, * Those with bilateral lower extremity lymphedema, * Having upper or lower extremity edema due to systemic disease, * Those with active infection, * Patients more than 1.5 months after LVA surgery * Known to have mental and cognitive disorders * Those who were unable to communicate and cooperate were not included.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bilsev İnce

    Konya, Turkey (Türkiye)

  • Hanife Dogan

    Konya, Konya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.